The stock of Indoco Remedies will remain in focus on the bourses, as the company informed the exchanges, after market hours, about receiving the US Food & Drugs Administration’s approval for its facility in Goa.
Based on the inspection carried out by the USFDA in August 2013, Indoco Remedies has received Establishment Inspection Report approving the company’s sterile plant and solid dosage facility in Goa. Analysts will be watching the developments.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.